You are here

Article info

Article menu
Download PDFPDF
Clinical science
High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome

Authors

  1. Correspondence to Dr Stefan Seregard, St Eriks Eye Hospital, Polhemsgatan 50, Stockholm SE 11282, Sweden; stefan.seregard{at}sankterik.se
View Full Text

Citation

Fili M, Lundell G, Lundell M, et al
High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome
British Journal of Ophthalmology 2014;98:1349-1354.

Publication history

  • Received February 7, 2014
  • Revised March 22, 2014
  • Accepted April 16, 2014
  • First published May 13, 2014.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions